Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-000808
Filing Date
2024-09-10
Accepted
2024-09-10 16:39:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5185
  Complete submission text file 0001968582-24-000808.txt   6657
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41855 | Film No.: 241290529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 6TH FLOOR NEW YORK NY 10010
Business Address
Townsend Richard Nolan (Reporting) CIK: 0001995218 (see all company filings)

Type: 144